Hunter Land

Hunter Land

Guest Writer
Director of Cannabinoid Research at Canopy Growth Corporation

About Hunter Land

Hunter Land, director of cannabinoid research at Canopy Growth Corporation, has devoted his career to researching cannabis-derived medicines and their application across a variety of conditions, leading the clinical development of the first FDA-approved CBD medication, Epidolex.

More From Hunter Land

CBD Time

Risk Versus Reality: Here's What The Current Research On CBD Tells Us

When it comes to CBD, perhaps the greatest consumer health risk is the lack of a sensible, science-backed regulatory framework.